European Alliance for Access to Safe Medicines (EAASM)

Special ReportOpinionPromoted content
Health 16-12-2020

Pharmaceutical Strategy must do more to support nanomedicines

The EU’s Pharmaceutical Strategy must do more to support nanomedicines and protect patient safety. Here’s why. Mike Isles is the Executive Director of the European Alliance for Access to Safe Medicines (EAASM). If Europe is to make its world-leading pharmaceutical...